BABA vs JXG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.
JXG presents as a classic value trap; while the Piotroski F-Score of 5/9 indicates stable short-term financial health and the balance sheet is lean (Debt/Equity 0.12), these are overshadowed by catastrophic growth trends. Earnings have collapsed by 81.7% YoY and the stock has lost over 99% of its value over five years. Despite an extremely low Price-to-Book ratio of 0.06, the lack of revenue growth and severe price depreciation suggest the market is pricing in significant asset impairment or business model failure.
Compare Another Pair
Related Comparisons
BABA vs JXG: Head-to-Head Comparison
This page compares Alibaba Group Holding Limited (BABA) and JX Luxventure Group Inc. (JXG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.